1:30
New Drug Approved for Parkinson's Disease
FDA recently approved a new drug to treat Parkinson's disease, called Azilect (rasagiline)...
published: 11 Jun 2008
author: LawsuitGuru
New Drug Approved for Parkinson's Disease
New Drug Approved for Parkinson's Disease
FDA recently approved a new drug to treat Parkinson's disease, called Azilect (rasagiline). Azilect is an MAO type-B inhibitor that blocks the breakdown of d...- published: 11 Jun 2008
- views: 19031
- author: LawsuitGuru
4:13
Parkinson's med improves guitar
Bach Prelude to first cello suite with explaination of how guitar can be used to measure m...
published: 05 Oct 2010
author: wmcurtis4
Parkinson's med improves guitar
Parkinson's med improves guitar
Bach Prelude to first cello suite with explaination of how guitar can be used to measure mild cognitive impairment on a short time scale. Rivastigmine and ra...- published: 05 Oct 2010
- views: 447
- author: wmcurtis4
4:42
Parkinson's Alzheimer's drugs - Prof. Moussa Youdim
Approximately 7 million people suffer from Parkinson's and Alzheimer's diseases in the Uni...
published: 13 Apr 2011
author: Technion
Parkinson's Alzheimer's drugs - Prof. Moussa Youdim
Parkinson's Alzheimer's drugs - Prof. Moussa Youdim
Approximately 7 million people suffer from Parkinson's and Alzheimer's diseases in the United States alone. Prof. Moussa B.H. Youdim, Director of the Eve Top...- published: 13 Apr 2011
- views: 5099
- author: Technion
2:02
Pharmaceutical Drugs & Pharmaceutical PCD by Avyukt Pharmaceuticals, Bengaluru
http://www.avyuktpharmaceuticals.com/]Welcome to Avyukt Pharmaceuticals, Manufacturer and ...
published: 12 Jul 2013
author: Abhishek Bhartia
Pharmaceutical Drugs & Pharmaceutical PCD by Avyukt Pharmaceuticals, Bengaluru
Pharmaceutical Drugs & Pharmaceutical PCD by Avyukt Pharmaceuticals, Bengaluru
http://www.avyuktpharmaceuticals.com/]Welcome to Avyukt Pharmaceuticals, Manufacturer and Supplier of Pharmaceutical Drugs and Medicines . The company was c...- published: 12 Jul 2013
- views: 2
- author: Abhishek Bhartia
2:02
Ritalin Las Vegas 702-878-8888 Ritalin Doctor
http://www.TrimCare.com Ritalin Las Vegas - Ritalin Doctor Goldsmith has treated hundreds ...
published: 24 Dec 2013
Ritalin Las Vegas 702-878-8888 Ritalin Doctor
Ritalin Las Vegas 702-878-8888 Ritalin Doctor
http://www.TrimCare.com Ritalin Las Vegas - Ritalin Doctor Goldsmith has treated hundreds of patient with Ritalin who suffer from ADHD. For an appointment please call (702) 878-8888. Ritalin Las Vegas - Ritalin (methylphenidate) is a central nervous system stimulant. It affects chemicals in the brain and nerves that contribute to hyperactivity and impulse control. Ritalin is used to treat attention deficit disorder (ADD) and attention deficit hyperactivity disorder (ADHD). It is also used in the treatment of a sleep disorder called narcolepsy (an uncontrollable desire to sleep). When given for attention deficit disorders, Ritalin should be an integral part of a total treatment program that may include counseling or other therapies. Do not use Ritalin if you have taken an MAO inhibitor in the past 14 days. A dangerous drug interaction could occur. MAO inhibitors include isocarboxazid, linezolid, phenelzine, rasagiline, selegiline, and tranylcypromine. You should not use Ritalin if you are allergic to methylphenidate or if you have: glaucoma; a personal or family history of tics (muscle twitches) or Tourette's syndrome; or severe anxiety, tension, or agitation (methylphenidate can make these symptoms worse). Tell your doctor if you have any heart problems. Some stimulants have caused sudden death in people with serious heart problems or congenital heart defects. Tell your doctor if you have: heart disease, heart rhythm disorder; coronary artery disease (hardened arteries); or history of heart attack. To make sure Ritalin is safe for you, tell your doctor if you have: high blood pressure; a personal or family history of mental illness, psychotic disorder, bipolar illness, depression, or suicide attempt; peripheral vascular disease such as Raynaud's syndrome; epilepsy or other seizure disorder; tics (muscle twitches) or Tourette's syndrome; a stomach disorder; or a history of drug or alcohol addiction. Ritalin may be habit forming. Never share this medicine with another person, especially someone with a history of drug abuse or addiction. FDA pregnancy category C. It is not known whether Ritalin will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication. Methylphenidate can pass into breast milk and may harm a nursing baby. You should not breast-feed while using this medicine. Long-term use of Ritalin can slow a child's growth. Tell your doctor if the child using this medication is not growing or gaining weight properly. Do not give Ritalin to a child younger than 6 years old without a doctor's advice. TrimCare 5375 S Fort Apache Rd#102 Las Vegas, NV 89148 (702) 367-0808 http://www.youtube.com/watch?v=nzn8kjxoHrg- published: 24 Dec 2013
- views: 2
70:29
Parkinson's: The Latest Approaches
"Falls, hallucinations, depression, dementia... everyone knows about the Masked Face of Pa...
published: 14 Jan 2014
Parkinson's: The Latest Approaches
Parkinson's: The Latest Approaches
"Falls, hallucinations, depression, dementia... everyone knows about the Masked Face of Parkinson's but what about the rest!" Associate Professor Simon Lewis Parkinson's disease is a chronic life long condition. It is the most common neurodegenerative disorder in Australia after Alzheimer's disease, with gradual onset and slow progression. Symptoms include tremor, rigidity, slowness of movement and impaired balance. The presentation of symptoms varies greatly between individuals diagnosed and no two people will be affected in the same way. A primary health care practice of 1,700 patients would have, on average, 4 patients with Parkinson's disease. Rural living is a statistically significant risk factor. This debilitating condition presents many and varied challenges for both the person with Parkinson's and their carers. With no known cure, treatment aims to minimise the impact of the symptoms on the person's quality of life. The individual treatment regimen needs to be reviewed and, when necessary, modified as the disease progresses. As with any complex chronic medical condition, management of people with Parkinson's can be enhanced by the holistic and ongoing care of a multidisciplinary health care team. This program looks at the latest advances in diagnosis, treatment and ongoing management of symptoms. Different models of care are examined, and the evidence-based pharmacological and non-pharmacological treatments are discussed. Produced by the Rural Health Education Foundation http://www.rhef.com.au/- published: 14 Jan 2014
- views: 108
6:48
يسجلني باسم الكربلائي 1433 Bassim Karbalai 2012 Yisajilni
يسجلني كامله باسم الكربلائي 2012 Bassim Karbalai....
published: 14 Jan 2012
author: Khyyber
يسجلني باسم الكربلائي 1433 Bassim Karbalai 2012 Yisajilni
يسجلني باسم الكربلائي 1433 Bassim Karbalai 2012 Yisajilni
يسجلني كامله باسم الكربلائي 2012 Bassim Karbalai.- published: 14 Jan 2012
- views: 114186
- author: Khyyber
3:04
Breakthrough Research on Parkinson's and Alzheimer's Diseases
See how researchers deciphered the neurogenerative process and developed the potent new dr...
published: 03 Dec 2010
author: TechnionSociety
Breakthrough Research on Parkinson's and Alzheimer's Diseases
Breakthrough Research on Parkinson's and Alzheimer's Diseases
See how researchers deciphered the neurogenerative process and developed the potent new drug, Azilect, to treat symptoms of Parkinson's and actually slow deg...- published: 03 Dec 2010
- views: 584
- author: TechnionSociety
4:27
Prof. Moussa Youdim -- Neurodegenerative Disease Therapies
Interview with Prof. Moussa B.H. Youdim of Technion's Rappaport Faculty of Medicine. Prof....
published: 08 Jun 2010
author: Technion
Prof. Moussa Youdim -- Neurodegenerative Disease Therapies
Prof. Moussa Youdim -- Neurodegenerative Disease Therapies
Interview with Prof. Moussa B.H. Youdim of Technion's Rappaport Faculty of Medicine. Prof. Youdim discusses neurodegenerative disease therapies including new...- published: 08 Jun 2010
- views: 9568
- author: Technion